Wednesday, December 12, 2018 9:55:52 AM
As an investor, you should be interested in the market cap of DECN, right. As well as eventual share price. The amount of money Bozo Berman needs to distribute any product will be highly dilutive, so investments in DECN on a stock level is a joke. Without audited financials, there will be no serious investors.
Having approved FDA products is great, and that is the only thing I would give Bozo Berman good grades on, but what good is it if there are pathetic sales.
Stock investors are pretty much screwed here. Maybe if your cost is .02 you might make a few bucks, even then I doubt it.
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM